ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 01535110. A total of 4 filers reported holding ALEXION PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $41,302,000 | +0.9% | 248,148 | -5.3% | 0.16% | +6.8% |
| Q2 2014 | $40,925,000 | +2.3% | 261,917 | -0.4% | 0.15% | -2.7% |
| Q1 2014 | $39,992,000 | +9.1% | 262,879 | -2.6% | 0.15% | +7.9% |
| Q4 2013 | $36,654,000 | +48.1% | 269,980 | +0.6% | 0.14% | +33.7% |
| Q3 2013 | $24,752,000 | +0.0% | 268,343 | 0.0% | 0.10% | 0.0% |
| Q2 2013 | $24,751,000 | – | 268,343 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telluride Asset Management LLC | 2,870 | $448,000 | 0.38% |
| Mizuho Trust & Banking Co., Ltd. | 261,917 | $40,925,000 | 0.15% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 75,467 | $11,792,000 | 0.06% |
| INGALLS & SNYDER LLC | 4,000 | $625,000 | 0.03% |